UBS Adjusts Price Target on STAAR Surgical to $19 From $20, Keeps Sell Rating
UBS has adjusted its price target for STAAR Surgical Company (STAA) to $19, down from $20, while maintaining a Sell rating on the stock. This update reflects the analyst's current outlook on the medical equipment company. The article also notes recent company activities including …